Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

182 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A phase 1 trial of vadastuximab talirine as monotherapy in patients with CD33-positive acute myeloid leukemia.
Stein EM, Walter RB, Erba HP, Fathi AT, Advani AS, Lancet JE, Ravandi F, Kovacsovics T, DeAngelo DJ, Bixby D, Faderl S, Jillella AP, Ho PA, O'Meara MM, Zhao B, Biddle-Snead C, Stein AS. Stein EM, et al. Among authors: fathi at. Blood. 2018 Jan 25;131(4):387-396. doi: 10.1182/blood-2017-06-789800. Epub 2017 Dec 1. Blood. 2018. PMID: 29196412 Free PMC article. Clinical Trial.
Chronic myelogenous leukemia.
O'Brien S, Abboud CN, Akhtari M, Altman J, Berman E, DeAngelo DJ, Devine S, Fathi AT, Gotlib J, Jagasia M, Moore JO, Pinilla-Ibarz J, Radich JP, Reddy VV, Shah NP, Shami PJ, Smith BD, Snyder DS, Wetzler M, Yunus F; National Comprehensive Cancer Network. O'Brien S, et al. Among authors: fathi at. J Natl Compr Canc Netw. 2012 Jan;10(1):64-110. doi: 10.6004/jnccn.2012.0009. J Natl Compr Canc Netw. 2012. PMID: 22223870 No abstract available.
Prospective serial evaluation of 2-hydroxyglutarate, during treatment of newly diagnosed acute myeloid leukemia, to assess disease activity and therapeutic response.
Fathi AT, Sadrzadeh H, Borger DR, Ballen KK, Amrein PC, Attar EC, Foster J, Burke M, Lopez HU, Matulis CR, Edmonds KM, Iafrate AJ, Straley KS, Yen KE, Agresta S, Schenkein DP, Hill C, Emadi A, Neuberg DS, Stone RM, Chen YB. Fathi AT, et al. Blood. 2012 Nov 29;120(23):4649-52. doi: 10.1182/blood-2012-06-438267. Epub 2012 Oct 16. Blood. 2012. PMID: 23074281 Free article.
Phase I dose escalation study of bortezomib in combination with lenalidomide in patients with myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML).
Attar EC, Amrein PC, Fraser JW, Fathi AT, McAfee S, Wadleigh M, Deangelo DJ, Steensma DP, Stone RM, Foster J, Neuberg D, Ballen KK. Attar EC, et al. Among authors: fathi at. Leuk Res. 2013 Sep;37(9):1016-20. doi: 10.1016/j.leukres.2013.05.011. Epub 2013 Jun 15. Leuk Res. 2013. PMID: 23773898 Free PMC article. Clinical Trial.
The evolving landscape in the therapy of acute myeloid leukemia.
Peloquin GL, Chen YB, Fathi AT. Peloquin GL, et al. Among authors: fathi at. Protein Cell. 2013 Oct;4(10):735-46. doi: 10.1007/s13238-013-3057-2. Epub 2013 Aug 27. Protein Cell. 2013. PMID: 23982740 Free PMC article. Review.
Chronic Myelogenous Leukemia, Version 1.2014.
O'Brien S, Radich JP, Abboud CN, Akhtari M, Altman JK, Berman E, DeAngelo DJ, Deininger M, Devine S, Fathi AT, Gotlib J, Jagasia M, Kropf P, Moore JO, Pallera A, Pinilla-Ibarz J, Reddy VV, Shah NP, Smith BD, Snyder DS, Wetzler M, Gregory K, Sundar H; Ntational comprehensive cancer network. O'Brien S, et al. Among authors: fathi at. J Natl Compr Canc Netw. 2013 Nov;11(11):1327-40. doi: 10.6004/jnccn.2013.0157. J Natl Compr Canc Netw. 2013. PMID: 24225967 Free PMC article.
182 results